Memorial Sloan Kettering Cancer Center Named World’s Best Cancer Hospital in Newsweek 2027 Ranking
Memorial Sloan Kettering Cancer Center Named World’s Best Cancer Hospital in Newsweek 2027 Ranking Oncodaily
Онкология
🎗️Лента новостей
Онкология
Оренбургские онкологи внедрили новые методы лечения неоперабельных пациентов и цифровой мониторинг
Оренбургские онкологи внедрили новые методы лечения неоперабельных пациентов и цифровой мониторинг Правда.Ру
Онкология
National Ovarian Cancer Awareness Month: Advancing Precision Medicine to Overcome Treatment Resistance
National Ovarian Cancer Awareness Month: Advancing Precision Medicine to Overcome Treatment Resistance University of Colorado Anschutz
🎗️
Онкология
Phase 3 mRNA Vaccine Results: What Does This Mean for Melanoma?
Phase 3 mRNA Vaccine Results: What Does This Mean for Melanoma? Oncology News Central
Онкология
OncoCorridor Launches to Connect Cancer Patients in War Zones With Care – ICC
OncoCorridor Launches to Connect Cancer Patients in War Zones With Care – ICC Oncodaily
Онкология
Gustave Roussy Named Europe’s No. 1 Cancer Center and Third Worldwide in Newsweek 2027 Ranking
Gustave Roussy Named Europe’s No. 1 Cancer Center and Third Worldwide in Newsweek 2027 Ranking Oncodaily
Онкология
Michelle Mitchell: Cancer Research UK Engages With New National Cancer Board
Michelle Mitchell: Cancer Research UK Engages With New National Cancer Board Oncodaily
Онкология
'Plug-and-play' CAR T technology adapts as cancer changes
Researchers from City of Hope have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. Published in Cancer Immunology Research, the…
Онкология
Alert-based patient-reported outcome monitoring reduces fatigue, breast cancer study shows
Alert-based patient-reported outcome monitoring reduces fatigue, breast cancer study shows Hospital Healthcare Europe
Онкология
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer Oncodaily
Онкология
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer BioSpace
Онкология
Saturated fat increases the risk of mortality in non-metastatic prostate cancer
Saturated fat increases the risk of mortality in non-metastatic prostate cancer Clinical Trials Arena
🎗️
Онкология
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026 Business Wire
Онкология
What drives time-to-randomization in oncology trials?
What drives time-to-randomization in oncology trials? clinicaltrialsarena.com